Glukoza 20 Braun (Glucose Monohydrate)

Glukoza 20 Braun is used in clinical practice to provide a rapid source of glucose when oral intake is not possible or when blood glucose needs to be supported.

• Maintenance of blood glucose levels during surgical procedures or anesthesia.
• Treatment of acute hypoglycemia when oral glucose is unsuitable.
• Component of parenteral nutrition regimens for patients unable to eat.
• Support during prolonged fasting or critical illness.
• Assisting in certain diagnostic tests that require controlled glucose infusion.
• Stabilizing glucose levels in patients with metabolic disorders.

Side effects associated with intravenous glucose solutions can vary in frequency and severity.

Common

• Mild hyperglycemia (elevated blood glucose).
• Local irritation at the infusion site.
• Nausea or mild gastrointestinal discomfort.
• Transient electrolyte shifts, such as low potassium.
• Headache or dizziness related to rapid glucose changes.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Hyperosmolar hyperglycemic state in susceptible individuals.
• Allergic reaction or anaphylaxis to formulation components.
• Fluid overload or pulmonary edema in patients with cardiac compromise.
• Severe electrolyte disturbances, such as hyponatremia.

When administering Glukoza 20 Braun, clinicians should consider several safety measures.

• Verify patient’s blood glucose level before infusion to avoid excessive hyperglycemia.
• Adjust infusion rate in patients with renal or cardiac insufficiency to prevent fluid overload.
• Monitor electrolytes, especially potassium and sodium, during prolonged therapy.
• Use aseptic technique to reduce risk of infection at the IV site.
• Exercise caution in patients with known hypersensitivity to glucose solutions or excipients.
• Document infusion details and patient response in the medical record.

Glucose infusions can interact with other medications or clinical conditions.

Avoid

• Concurrent administration of high-dose insulin without appropriate glucose monitoring.
• Use with drugs that may cause severe hypoglycemia, such as sulfonylureas, without adjusting doses.
• Co‑infusion with hypertonic solutions that could exacerbate hyperosmolar states.

Use with caution

• Beta‑blockers, which may mask symptoms of hypoglycemia.
• Corticosteroids, which can increase blood glucose levels.
• Diuretics that affect electrolyte balance.
• Medications that influence renal function, requiring closer monitoring of fluid status.